IPCSH - CENPAT   25618
INSTITUTO PATAGONICO DE CIENCIAS SOCIALES Y HUMANAS "DRA. MARÍA FLORENCIA DEL CASTILLO BERNAL"
Unidad Ejecutora - UE
artículos
Título:
Placental 11 β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) expression very early during human pregnancy
Autor/es:
MILANO K; NEPOMNASCHY, PABLO ANDRES; SALVANTE KG; KLIMAN HJ
Revista:
Journal of Developmental Origins of Health and Disease
Editorial:
Cambridge University Press
Referencias:
Lugar: Cambridge; Año: 2017
ISSN:
2040-1744
Resumen:
Maternal physiologic stress during gestation has been reported to be associated with negative developmental outcomes, including intra-uterine growth restriction and reduced birth weight, which can impact postnatal development, behavior and health. The human fetus is partially protected from elevated cortisol exposure by placental 11 β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which oxidizes bioactive cortisol into bio-inactive cortisone. Importantly, despite the critical protective role hypothesized for 11β-HSD2, the onset of its placental expression has yet to be clearly established. To this aim, we present immunocytochemical analysis of placentas collected 3?6 weeks post-conception. 11β-HSD2 was present as early as 3 weeks post-conception in syncytiotrophoblasts, where most maternal?fetal exchange occurs, and in columnar epithelial cells encircling uterine endometrial glands, which provide early histiopathic nutrition to the embryo. 11β-HSD2 expression in these critical maternal?fetal exchange areas is consistent with its hypothesized protective role. Future studies should investigate the mechanisms that may modulate embryonic glucocorticoid exposure earlier, immediately post-conception.